Cutaneous Squamous Cell Carcinoma in Patients with Solid Organ Malignancy Supplemental Table 1

Published: 27 December 2023| Version 1 | DOI: 10.17632/v4cvwt8pzr.1
, Emily Granger,
, Emily Karn,


The objective of this study is to evaluate the incidence, tumor characteristics, and outcomes of cSCC in patients with SOM compared to patients with no history of SOM. We conducted a multivariate analysis to examine the association between solid organ malignancy and poor outcomes. Based on univariate analysis, models were adjusted for age, gender, and BWH stage. However, the findings did not reveal significant associations between history of solid organ malignancy and development of poor outcomes (Supplemental Table 1). Overall, the findings of this study indicate an elevated incidence of high-stage cutaneous squamous cell carcinoma among individuals with a prior history of solid organ malignancy. However, no definitive associations were established been SOM and adverse outcomes. Additional research is warranted to thoroughly examine the interplay between solid organ malignancy, cSCC tumorigenesis, and disease outcomes.



Brigham and Women's Hospital


Dermatology, Squamous Cell Carcinoma